TY - JOUR
T1 - Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN)
T2 - report of a feasibility randomized controlled trial
AU - O’Mahen, Heather A.
AU - Ramchandani, Paul G.
AU - King, Dorothy X.
AU - Lee-Carbon, Leonie
AU - Wilkinson, Esther L.
AU - Thompson-Booth, Chloe
AU - Ericksen, Jennifer
AU - Milgrom, Jeannette
AU - Dunkley-Bent, Jacqueline
AU - Halligan, Sarah L.
AU - Fearon, Pasco
N1 - Funding Information:
This paper presents independent research funded by the National Institute for Health Research (NIHR), Research for Patient Benefit (RfPB) programme (PR: Grant Reference Number PB-PG-1112-29054) and Economic and Social Research Council (ESRC) Impact Accelerator Award (HOM: ACORN: Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy. This study was sponsored by Central and North West London NHS Foundation Trust ( www.cnwl.nhs.uk ). The sponsor and funding body did not have any role in the design of the study, in the writing of the manuscript, or in the decision to submit the manuscript for publication and will not contribute to the collection, analysis, and interpretation of data. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the ESRC, or the Department of Health. The study was supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for North West London.
PY - 2022/2/17
Y1 - 2022/2/17
N2 - Background: We investigated the acceptability and feasibility of a new brief intervention for maternal prenatal anxiety within maternity services in London and Exeter, UK. Methods: One hundred fourteen pregnant individuals attending their 12-week scan at a prenatal clinic with elevated symptoms of anxiety (GAD-7 score of ≥7) were randomly assigned to either the ACORN intervention + Treatment as usual (TAU) (n = 57) or to usual care only (n = 57). The ACORN intervention consisted of 3 2-h group sessions, led by a midwife and psychological therapist, for pregnant individuals and their partners. The intervention included psychoeducation about anxiety, strategies for problem-sovling and tolerating uncertainty during pregnancy, including communicating about these with others, and mindfulness exercises. Results: Engagement rates with ACORN met or exceeded those in primary care services in England. In the intervention arm, 77% (n = 44) of participants attended at least one session, 51% (n = 29) were adherent, defined as attending two or more sessions. Feedback was positive, and participants in the ACORN treatment group demonstrated evidence of a larger drop in their levels of anxiety than the participants in the TAU-only group (Cohen’s d = 0.42). Conclusion: The ACORN intervention was acceptable to pregnant individuals and their partners and resulted in reductions in anxiety. With further evaluation in a larger-scale trial with child outcomes, there is significant potential for large scale public health benefit.
AB - Background: We investigated the acceptability and feasibility of a new brief intervention for maternal prenatal anxiety within maternity services in London and Exeter, UK. Methods: One hundred fourteen pregnant individuals attending their 12-week scan at a prenatal clinic with elevated symptoms of anxiety (GAD-7 score of ≥7) were randomly assigned to either the ACORN intervention + Treatment as usual (TAU) (n = 57) or to usual care only (n = 57). The ACORN intervention consisted of 3 2-h group sessions, led by a midwife and psychological therapist, for pregnant individuals and their partners. The intervention included psychoeducation about anxiety, strategies for problem-sovling and tolerating uncertainty during pregnancy, including communicating about these with others, and mindfulness exercises. Results: Engagement rates with ACORN met or exceeded those in primary care services in England. In the intervention arm, 77% (n = 44) of participants attended at least one session, 51% (n = 29) were adherent, defined as attending two or more sessions. Feedback was positive, and participants in the ACORN treatment group demonstrated evidence of a larger drop in their levels of anxiety than the participants in the TAU-only group (Cohen’s d = 0.42). Conclusion: The ACORN intervention was acceptable to pregnant individuals and their partners and resulted in reductions in anxiety. With further evaluation in a larger-scale trial with child outcomes, there is significant potential for large scale public health benefit.
KW - Antenatal
KW - Anxiety
KW - Pregnancy
KW - Randomised controlled trial
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=85124777957&partnerID=8YFLogxK
U2 - 10.1186/s12888-022-03737-1
DO - 10.1186/s12888-022-03737-1
M3 - Article
C2 - 35177019
AN - SCOPUS:85124777957
VL - 22
JO - BMC Psychiatry
JF - BMC Psychiatry
SN - 1471-244X
IS - 1
M1 - 129
ER -